Division of Microbiology and Infectious Diseases, (DMID) 21-0018: Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae
Latest Information Update: 21 Mar 2025
At a glance
- Drugs Cefixime (Primary) ; Ceftriaxone (Primary) ; Ciprofloxacin (Primary) ; Diphtheria-tetanus vaccine (Primary) ; GSK 2282512A (Primary) ; Meningococcal vaccine group B OMV Novartis (Primary)
- Indications Gonorrhoea
- Focus Therapeutic Use
Most Recent Events
- 19 May 2022 Status changed from not yet recruiting to recruiting.
- 31 Mar 2022 New trial record